---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-302022"
form_type: "8-K"
ticker: "NPCE"
cik: "0001528287"
company_name: "NeuroPace Inc"
filed_at: "2021-10-19T23:59:59+00:00"
generated_at: "2026-06-28T19:58:21.595116+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# NeuroPace appoints Lisa Andrade as Class II director, replacing Evan Norton

## Summary
- Evan Norton resigned as Class II director effective Nov 1, 2021; no disagreement cited.
- Lisa Andrade appointed as Class II director effective Nov 1, 2021, term through 2023 annual meeting.
- Andrade will serve on Audit and Compensation Committees.
- She receives a stock option with $185K grant-date fair value, monthly vesting over 3 years.
- Annual cash retainers: $40K board, $10K audit, $7,500 compensation.

## SEC filing metadata
- accession: 0001193125-21-302022
- form_type: 8-K
- ticker: NPCE
- cik: 0001528287
- company_name: NeuroPace Inc
- filed_at: 2021-10-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1528287/000119312521302022/0001193125-21-302022-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1528287/000119312521302022/d26236d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-302022
- JSON: https://secwatch.observer/filing/0001193125-21-302022.json
- Plain text: https://secwatch.observer/filing/0001193125-21-302022.txt

## Key facts
- Executive change
  Lisa Andrade was appointed as Class II director at NeuroPace Inc.
  - Action: appointed
  - Role: Class II director
  source text: On October 15, 2021, the Board appointed Lisa Andrade as a Class II director to fill the vacancy created by Mr. Norton’s resignation, effective as of November 1, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1528287/000119312521302022/0001193125-21-302022-index.htm
- Executive change
  Evan Norton resigned as Class II director at NeuroPace Inc.
  - Action: resigned
  - Role: Class II director
  source text: On October 14, 2021, Evan Norton, a Class II director, resigned from the Board of Directors (the “Board”) (including the Compensation Committee and Audit Committee) of NeuroPace, Inc., effective as of November 1, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1528287/000119312521302022/0001193125-21-302022-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.